Ethylene vinyl alcohol copolymer erosions after use as a urethral bulking agent

Obstetrics and Gynecology

Volumn 109, Issue 2 PART 2 SUPPL., 2007, Pages 490-492

  Erekson, Elisabeth A ^a   Sung, Vivian W ^a   Rardin, Charles R ^a   Myers, Deborah L ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE VINYL ALCOHOL COPOLYMER;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CYSTOSCOPY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; STRESS INCONTINENCE; URETHRA DISEASE; URETHRA EROSION; URETHRA SURGERY; URODYNAMICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DATABASES, FACTUAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INJECTIONS; POLYVINYLS; PROSTHESES AND IMPLANTS; URETHRA; URINARY INCONTINENCE, STRESS;

EID: 33846457885     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000252261.55000.b2     Document Type: Article

References (5)

1. Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formation following bulking agent injection for the treatment urinary incontinence. J Urol 2006;175:1408-10.
2. U.S. Food and Drug Administration. New device approval. URYX urethral bulking agent - P030030. Available at: http://www.fda.gov/cdrh/mda/docs/p030030. html. Retrieved August 9, 2006.
3. U.S. Food and Drug Administration. Center for Devices and Radiologic Health. Search MAUDE database. Available at: http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfMAUDE/search.CFM. Retrieved August 9, 2006.
4. Lemmens DA. Tegress: a new approach to urethral implants. Urol Nurs 2006;26:77-9.
5. C. R. Bard, Inc. Tegress urethral implant. Available at: http://www.bardurological.com/products/loadProduct.aspx?bUnitID=2&prodID= 279. Retrieved August 9, 2006.